PATHOLYTIX LIMITED

Patholytix Limited is a technology‑driven pathology company that provides a complete, regulated ecosystem for digital pathology. Its flagship Patholytix 3.0 platform delivers a scalable, GLP‑compliant solution that integrates slide viewing, image quality control, secure storage, AI‑powered decision support and whole‑slide‑image‑synced data capture, enabling pathologists and drug‑development teams to review findings, score studies and launch compounds far more quickly than traditional workflows.

Key services include a data‑capture module that allows digital review and scoring of drug‑discovery studies, an Image QC suite that achieves image‑quality control at speeds beyond human capability, AI solutions that accelerate critical decision‑making, end‑to‑end GLP‑compliant digital study management—a world‑first—and a scanning service that unlocks historical pathology knowledge. Headquartered in Dublin, Ireland, with additional sites in the United States and the United Kingdom, Patholytix serves pharmaceutical companies, clinical‑trial organisations and pathology laboratories seeking faster, more reliable, and fully compliant digital pathology workflows.